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Abstract
Background: Both tobacco smoking and depression are major public health problems associated with high morbidity and
mortality. In addition, individuals with depression are almost twice as likely to smoke and less likely to achieve smoking cessation.
In the Smoking Treatment for Ontario Patients program, an established smoking cessation program in Ontario, Canada, 38% of
smokers in primary care settings have current or past depression with 6-month quit rates that are significantly lower than those
without depression (33% versus 40%, P<.001). Integrating self-help mood management (eg, relaxation exercises and mood
monitoring) with smoking cessation treatment increases long-term quit rates by 12%-20%. However, integration in real-world
settings has not been reported. It is unclear which knowledge translation strategy would be more effective for motivating clinicians
to provide resources on mood management to eligible patients.
Objective: The objectives of this study are to investigate the following comparisons among depressed smokers enrolled in a
smoking cessation program: 1) the effectiveness of generalized, exclusively email-based prompts versus a personalized knowledge
broker in implementing mood management interventions; 2) the effectiveness of the two knowledge translation strategies on
smoking quit rates; and 3) the incremental costs of the two knowledge translation strategies on the implementation of mood
management interventions.
Methods: The study design is a cluster randomized controlled trial of Family Health Teams participating in the Smoking
Treatment for Ontario Patients program. Family Health Teams will be randomly allocated 1:1 to receive either generalized
messages (related to depression and smoking) exclusively via email (group A) or be assigned a knowledge broker who provides
personalized support through phone- and email-based check-ins (group B). The primary outcome, measured at the site level, is
the proportion of eligible baseline visits that result in the provision of the mood management intervention to eligible patients.
Results: Recruitment for the primary outcome of this study will be completed in 2018/2019. Results will be reported in
2019/2020.
Conclusions: This study will address the knowledge gap in the implementation strategies (ie, email-based prompts versus a
knowledge broker) of mood management interventions for smokers with depression in primary care settings.
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Introduction
Background
Both tobacco smoking and depression are major public health
problems with high morbidity and mortality [1-4]. Individuals
with depression are almost twice as likely to be smokers [5-7],
have lower long-term smoking abstinence (odds ratio [OR] 0.81,
95% CI 0.67-0.97) [1], and experience greater addiction severity
and negative mood when quitting smoking [8-11].
Self-help mood management (eg, relaxation exercises and mood
monitoring) integrated with smoking cessation treatment
increases long-term quit rates by 12%-20% [3,4,12-15].
However, it remains unclear what knowledge translation (KT)
strategy would be most effective in engaging practitioners to
implement a mood management integrated care pathway (ICP)
into primary care settings [16-20]. Two strategies that are
commonly used in Canada to promote evidence-based practices
include email communications and knowledge brokers (KBs)
[17]. Emails provide targeted messages that connect relevant
research evidence to specific practitioners, while KBs work
one-on-one with practitioners to facilitate the implementation
of an evidence-informed intervention [21] Several studies have
shown that context where the intervention is being implemented
is essential to take into account, in deciding which KT strategy
to use [16,17]. Unfortunately, it is not known which of these
KT strategies would be the most effective among Family Health
Teams (FHTs) in Ontario, Canada. In Ontario, FHTs are primary
health care organizations that include a team of family
physicians, nurse practitioners, registered nurses, social workers,
dietitians, and other professionals who work together to provide
primary health care for their community [21].
Objective
This study aims to assess whether email updates versus a KB
(who will communicate with health care providers on an
as-needed basis) is more effective at enabling practitioners
within FHTs to provide their patients with mood management
resources when needed. In addition, it will explore which of
these KT strategies has the greatest effect on smoking abstinence
and depressive symptoms at time of follow-up. We will also
examine the incremental cost effectiveness of the two KT
strategies, the proportion of eligible smokers who report using
the resources, smoking cessation outcomes compared to patients
without depressive symptoms, and practitioner improvement
in knowledge, attitudes, skills, and satisfaction in addressing
depressive symptoms in smokers.
In this paper, we describe the protocol for a cluster randomized
trial. This design was chosen because the intervention cannot
be delivered to individual practitioners within a clinic without
substantial risk of contamination across study arms. The trial
will be operationalized through the Smoking Treatment for
Ontario Patients (STOP) program, an established smoking
cessation program in Ontario, Canada. The STOP program
offers up to 26 weeks of smoking cessation treatment, consisting
of nicotine replacement therapy and behavioral counseling, at
no cost to the patient.
Methods
Inclusion Criteria
Site Level
Family Health Teams (FHTs) in Ontario, Canada implementing
an existing smoking cessation program (ie, the STOP program)
and using the STOP’s online portal at the time of the study are
eligible to participate. All FHTs operational in the STOP
program as of November 2017 (n=153) will be eligible for
randomization, except for those that do not use the online
program portal at the time of patient enrollment (n=25). We
anticipate that 128 FHTs will be randomized into the trial.
Patient Level
In order for a participant to be eligible for the trial, their baseline
enrollment survey must be administered by the health care
provider, in English, into the online portal in real time, so that
the clinical interaction can be supported by the STOP portal.
Therefore, those patients who are administered the baseline
survey on paper, or in French, will be excluded. Patients, at the
time of enrollment, must have depression (determined by a
Patient Health Questionnaire [PHQ-9] score>9) or report a past
diagnosis of depression.
Pre-Implementation
To understand the needs of the FHTs and the importance of
treating depression in the smoking cessation program, we
developed a survey which measures organizational readiness
and the extent to which an organization is willing and able to
implement a specific intervention [22]. The survey consists of
12 questions addressing the six components of The National
Implementation Research Network’s Hexagon Tool (ie, need,
fit, resources, evidence, readiness, and capacity) [23], as well
as the three readiness components described by Scaccia et al
[24] (ie, motivation, general capacities, and specific capacities)
[24]. Based on answers to this survey, organizations were
grouped into two categories: most ready (n=44), and least ready
(n=40). Organizations that did not answer the questionnaire
(n=41) will be grouped together in a group labeled “unknown
readiness.” The detailed answers from this survey will be useful
for developing a KT strategy that will allow the project team
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to make informed decisions about their approach to change
management.
In order to increase practitioners’ competencies to deliver a
brief mood management, two interactive webinars will be
presented to communicate best practices for integrating
evidence-based mood interventions into smoking cessation
programming. The webinar audience will include the STOP
Community of Practice (n=300) consisting of implementers,
physicians, and executive directors, who interact through
bi-weekly teleconferences to communicate updates, clarify
procedures, address barriers or gaps in program delivery, and
share experiences with other practitioners.
Trial Design
Study clusters (ie, FHTs) will receive either generalized
messages (related to depression and smoking) exclusively
through email (group A) or be assigned a KB who will provide
personalized support through phone- and email-based check-ins
(group B).
Practitioners from group A will receive one email per month
for one year. The first email will provide an electronic copy of
a relevant Cochrane review [15], and a short description of the
new depression ICP that will be integrated into the STOP portal.
Subsequent communications will be based on general needs
identified throughout the study. Practitioners from group B will
receive individualized support from a KB communicating
through interactive technology (ie, Skype) on an as-needed
basis. The KB will be certified in tobacco cessation counseling
and will have completed a specialty course on tobacco addiction
treatment for individuals with mental illness [25,26].
Clinics are the unit of randomization. Two stratification factors
are defined: (1) organizational readiness (described previously)
with three levels, and (2) clinic size with two levels, resulting
in six strata. Expected clinic size will be estimated based on
past STOP enrollment because the actual number of eligible
trial participants clinics will enroll is not directly observable a
priori. Within each readiness stratum, the two levels of clinic
size were set such that expected total enrollment in the two
levels would be balanced. Within each of the six combined
strata, clinics were randomly allocated in a 1:1 allocation ratio
to control (group A) or intervention (group B). Treatment
allocation (randomization) for each clinic was determined for
all operational clinics en masse. Any clinic that began
implementing the STOP program after the randomization cut-off
date (Nov 14, 2017) will not be eligible for participation in the
trial. The random assignment of treatment to clinic was
computer generated using the ralloc command of statistical
computer software Stata V.14.
Blinding
This pragmatic, cluster trial is designed to evaluate an
intervention to change practitioners’ behavior. Blinding of the
clinic through its practitioners will therefore not be possible as
the practitioner will be aware of the presence or absence of the
KB. Participating clinics will not be informed of their treatment
allocation until the trial begins. Data analysis will be blinded
to treatment allocation.
Interventions
Patient Screening and Brief Intervention
Across all sites, practitioners will receive the same depression
ICP integrated into the STOP portal. Currently, patients are
asked to self-report on past diagnosis of depression and screened
for current depression using the PHQ-9. The PHQ-9 is a
self-completed, 9-item instrument with each item aligning with
the Diagnostic and Statistical Manual of Mental Disorders
(version IV)’s criteria for depression, and developed specifically
for use in primary care [27,28]. As part of the new ICP, the
STOP portal will identify patients screened as having current
or past depression, and prompt practitioners to provide a brief
intervention and refer an evidence-based package of resources
[29,30] (see Figure 1). Brief intervention messaging will be
designed using the Canadian Network for Mood and Anxiety
Treatments guidelines [31] and tailored to patients’ depression
levels based on their PHQ-9 score. Levels can range anywhere
from low risk of depression, which would warrant the usual
standard of care, to major depression with severe consequences
[31]. If patients’ screening results indicate risk of moderate or
severe depression, practitioners will be prompted to consult
with a team physician to determine next steps (eg, medication
adjustment or psychiatric referral). For patients who endorse
suicidal ideation, the ICP will guide practitioners to conduct an
additional assessment. Whenever an intervention is warranted,
practitioners will be encouraged to discuss other health risk
behaviors that influence patient mood, including alcohol use
and stress. Figure 1 presents a visual depiction of the study work
flow.
The evidence-based resource package, which practitioners will
be able to print or email it to patients, will include:
• Relaxation and mindfulness exercises
• Self-monitoring sheets to record each cigarette smoked, the
activities they engaged in, and overall mood at the end of
each day for 2 weeks
• Problem-solving attitudes and skills-building activities
Outcomes
The primary outcome will be the provision of the mood
management intervention to eligible patients upon completion
of the STOP smoking cessation program enrollment. This
dichotomous outcome will be measured as positive by a response
of “Patient accepted the resource” to the practitioner question
“Did the patient accept or decline the resource?”. In contrast,
the outcome will be measured as negative if given a response
of “Patient declined the resource” to the practitioner question
“Did the patient accept or decline the resource?” or a response
of “no” to the practitioner directive “Provide this patient with
resources on mood management.”
The secondary outcome will be patient smoking abstinence at
the 6-month follow-up survey, as measured by a negative
response to the seven-day point prevalence question “Have you
had a cigarette, even a puff, in the last 7 days?”. Self-reporting
has been verified as a valid estimate of smoking status [32].
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Figure 1. Study workflow diagram.
The tertiary outcome will be a cost-effectiveness analysis (CEA),
evaluating the delivery of each intervention from the health care
system, and societal perspectives. The CEA will include the
costs of developing, maintaining, and running each intervention
in addition to costs associated with personnel, training, supplies,
and services. The incremental cost-effectiveness ratio (ICER)
will be the primary outcome of the CEA. An additional measure
of interest will be the 95% confidence interval for the ICER,
which will be estimated using nonparametric bootstrap
resampling techniques [33-36]. This method is commonly used
when undertaking economic evaluations alongside clinical trials
[37,38].
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Other outcomes measured in this study will include change in
PHQ-9 score between the baseline and 6-month follow-up
surveys, the proportion of eligible smokers who report using
the materials, smoking cessation outcomes compared to patients
without depression, and practitioner improvement in knowledge,
attitudes, skills, and satisfaction in addressing depression in
smokers.
Covariates
Patient characteristics known to affect quit outcomes include
age, gender, socioeconomic status, having a quit date, alcohol
and other substance use, other mental health diagnosis and the
Heaviness of Smoking Index [39]. Site and patient level
covariates will be treated as potential confounders in the
statistical analyses.
Sample Size
A sample size of 1224 patients per group (2446 total) was
estimated using a method that accounts for intracluster
correlation (ICC) within each FHT and uneven cluster sizes
[40]. Using past STOP enrollment as a data source, we estimated
an ICC of ρ=.032, cluster size variation coefficient of 1.24, an
average annual enrolment of 24 patients, the proportion of
control group patients who are provided the mood management
intervention (p1) to be 0.08, and set alpha=.05 and power=.80.
The minimum desired effect size was set at a risk
difference=0.06. Based on enrollment in 2016-2017, we estimate
the required sample size for the primary outcome will be
achieved in less than 12 months.
Statistical Analysis
All analyses will adopt an intention-to-treat principle in which
sites and patients will be analyzed in the trial arm to which they
are randomized. Cluster specific methods will be used because
the practices, rather than patients, will be randomized, and
variance in how patients are managed, and in patient quit
outcomes, will be partly explained by the practice.
Primary and Secondary Outcomes
The association between the KT intervention and the primary
outcome (ie, delivery of mood management interventions) will
be analyzed using a generalized estimating equation (GEE)
fitted for logistic regression, using a population-averaged
method. Stratification variables will be included as covariates.
An exchangeable correlation matrix and robust standard errors
will be specified. All outcomes are recoded by the STOP portal
system and thus a full case analysis will be used.
The association between KT intervention and the secondary
outcome (ie, smoking abstinence at 6-month follow-up) will be
analyzed using a GEE as described above. All patients are
invited to complete the 6-month follow-up survey, but not all
do, so missing outcome data are expected. Therefore, we will
conduct a single imputation of the best-case scenario (all patients
not smoking) and a single imputation of the worst-case scenario
(all patients smoking). If the analyses from the two case
scenarios imply different conclusions, multiple imputations will
be performed accounting for the clustered structure of the data.
All study analyses will be performed in Stata 14 [41].
Tertiary Outcomes
In order to conduct a cost-effectiveness analysis, we will
estimate an ICER for two outcomes: number of times resources
are provided to patients (health provider side) and smoking quit
rates (patient side). The ICER will be calculated as the difference
in discounted mean costs between intervention groups A and
B divided by the difference in the outcome, using the following
formula: ICER=(Ci–Cc)/(Ei–Ec), where Ci is the adjusted annual
costs of group B, Cc is the adjusted annual costs of group A, Ei
is the effect in group B, and Ec is the effect in group B. One-way
deterministic sensitivity analyses will be performed to evaluate
the robustness of our results.
Ethical Approval and Trial Status
The study was reviewed by the Research Ethics Board at the
Centre for Addiction and Mental Health (approval number:
065-2016). The trail is registered with ClinicalTrials.gov (ID:
NCT03130998). At the time of manuscript submission, the
readiness survey was administered, but recruitment was not
completed.
Results
Recruitment for the primary outcome of this study will be
completed in 2018/2019. Results will be reported in 2019/2020.
Discussion
It is well known that the process of integrating research evidence
into practice is slow and complex [42]. Even though there have
been many strategies evaluated to improve how health care
professionals care for their patients, there is still no clear answer
as to which is the most effective, and cost-effective, strategy to
use [16,17]. Two strategies that are commonly used to promote
practice change include (1) tailored and targeted messages that
connect relevant research evidence to practice users [43]; and
(2) KBs who work one-on-one with decision makers to facilitate
evidence-informed decision-making [16].
This clinical trial will address the knowledge gap in the
implementation approach associated with the use of email-based
prompts versus a KB in mood management interventions for
smokers with depression in primary care settings. With at least
one life saved from a tobacco-related death for every two
smokers who quit [44], the potential patient-level impact will
extend well beyond the study duration. Assuming both
approaches are equally effective at achieving a modest
probability (10%) of practice change and knowing there should
be a 12%-20% improvement in the likelihood of quitting
smoking due to use of a mood management intervention, we
would expect 19 to 32 patients with depression to quit smoking.
An additional benefit to patients will be a potential improvement
in their depression scores as a result of the specialized care and
resources provided by clinicians as part of this study.
In addition, the Web-based portal used by STOP overcomes the
issue of compatibility across various electronic medical records
in FHTs. Adding a depression intervention to this system could
lead to a system-wide implementation of integrated depression
care pathways at a relatively low cost, potentially reaching 2.25
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million Ontarians registered at these FHTs. Moreover, a
technology-based KB model will help reduce travel costs and
expand the reach of KBs in the future.
Finally, rapid and efficient implementation in other settings
participating in the STOP program, such as Community Health
Centres, addiction agencies, Public Health Units, and Nurse
Practitioner–Led Clinics, is possible at a relatively low cost.
We will also have high quality data on these populations for
planning and monitoring the effects of interventions in primary
care settings.
Some potential limitations should be acknowledged. As noted
earlier, health care practitioners will not be blinded to the
treatment allocation. During this study, a health care practitioner
might work in two different clinics, one assigned to group A,
and one to group B. In this case, there is the possibility of
contamination of knowledge, as the health care practitioner
might apply knowledge obtained from the KB advice received
while working in a group B clinic to patients in their group A
clinic. This possible contamination could decrease the trial effect
and lead to a more conservative effect estimate. However, we
anticipate that this will be a rare occurrence. In addition, there
is a risk that detecting change in the abstinence rates may be
underpowered when estimating the ICER for the economic
evaluation.
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